Loading...
In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
Three neuraminidase inhibitors (NAIs: Oseltamivir, zanamivir and peramivir) are currently approved in many countries for the treatment of influenza A and B infections. The emergence of influenza B viruses (IBVs) containing mutations of cross-resistance to these NAIs constitutes a serious clinical th...
Na minha lista:
| Udgivet i: | Viruses |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357004/ https://ncbi.nlm.nih.gov/pubmed/30583488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11010006 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|